Author

Xue-Yan Zhang

Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Observed institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital, Zhengzhou University, Zhengzhou People's Hospital

OpenAlex ID: A5113931759

Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway

2019 · Yong-An Song, Ting Ma, et al. · Cancer Cell International · 27

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation

2021 · Wei Nie, Lu Gan, et al. · OncoImmunology · 13

Works count: 2

Citation count: 40

H-index: 2

I10-index: 2